FRAKIDEX

This brand name is authorized in France, Tunisia

Active ingredients

The drug FRAKIDEX contains a combination of these active pharmaceutical ingredients (APIs):

1 Framycetin
UNII Y3720KZ4TQ - FRAMYCETIN SULFATE
Read about Framycetin
2 Dexamethasone
UNII AI9376Y64P - DEXAMETHASONE SODIUM PHOSPHATE

Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.

Read about Dexamethasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01CA01 Dexamethasone and antiinfectives S Sensory organs → S01 Ophthalmologicals → S01C Antiinflammatory agents and antiinfectives in combination → S01CA Corticosteroids and antiinfectives in combination
Discover more medicines within S01CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 60814943, 65164218
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 5283072, 5283073

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈